New Delhi [India], May 3 (ANI): India can easily do the synthesis of antiviral drug - Remdesivir - if allowed by the US-based pharma major Gilead Sciences, said Dr Nirmal K Ganguly, former Director-General, Indian Council of Medical Research (ICMR), on Saturday.
New Delhi [India], May 2 (ANI): Since the onset of global coronavirus pandemic, scientists, experts and medical practitioners are vigorously engaged in researching for the most effective treatment of COVID-19 patients. As per the experts, antiviral drug -- Remdesivir -- could be the answe